PHARMACOLOGICAL PROPERTIES OF OXOTREMORINE AND ITS ANALOGS

被引:59
作者
RINGDAHL, B [1 ]
JENDEN, DJ [1 ]
机构
[1] UNIV CALIF LOS ANGELES, INST BRAIN RES, LOS ANGELES, CA 90024 USA
关键词
D O I
10.1016/0024-3205(83)90365-X
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
引用
收藏
页码:2401 / 2413
页数:13
相关论文
共 82 条
[61]  
LUNDGREN GOSTA, 1966, LIFE SCI, V5, P977, DOI 10.1016/0024-3205(66)90003-8
[62]  
MACINTOSH FC, 1963, CAN J BIOCHEM PHYS, V41, P2555
[63]  
PALMER GC, 1981, NEUROPHARMACOLOGY CE
[64]  
RESUL B, 1979, ACTA PHARM SUEC, V16, P225
[65]  
RESUL B, 1981, EUR J MED CHEM, V16, P379
[66]   THE PHARMACOLOGICAL ASSESSMENT OF A NEW, POTENT OXOTREMORINE ANALOG IN MICE AND RATS [J].
RESUL, B ;
LEWANDER, T ;
RINGDAHL, B ;
ZETTERSTROM, T ;
DAHLBOM, R .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1982, 80 (2-3) :209-215
[67]  
RESUL B, 1982, EUR J MED CHEM, V17, P317
[68]   SYNTHESIS AND PHARMACOLOGICAL PROPERTIES OF N-[4-(1-AZETIDINYL)-2-BUTYNYL]-2-PYRROLIDONE, A HIGHLY POTENT OXOTREMORINE-LIKE AGENT [J].
RESUL, B ;
LEWANDER, T ;
ZETTERSTROM, T ;
RINGDAHL, B ;
MUHIELDEEN, Z ;
DAHLBOM, R .
JOURNAL OF PHARMACY AND PHARMACOLOGY, 1980, 32 (06) :439-440
[69]  
RESUL B, EUR J PHARM
[70]  
RINGDAHL B, 1979, ACTA PHARM SUEC, V16, P89